Company news
Synmosa Biopharma Corp (TPEX:4114) news
Synmosa Biopharma Corp news releases on 6ix. Latest, Aug 11, 2022: Synmosa Biopharma : To announces SYNMOSA board of directors has lifted the restriction…
Press releases & updates
Synmosa Biopharma : To announces SYNMOSA board of directors has lifted the restriction on the prohibition of competition for managerial officer
August 11, 2022
Synmosa Biopharma : The Company's 2022 Second quarter consolidated financial statements have been reported to the Board
August 11, 2022
Synmosa Biopharma : Announcement of the Company's adjustment of the number for the transfer treasury shares to employees through the resolution of the board of directors on 7/29
August 2, 2022
Synmosa Biopharma : Announcement of the Company's board of directors resolution on transfer treasury shares to employees and the record date of share subscription
July 29, 2022
Synmosa Biopharma : announces the record date for 2021 dividend through retained earning.
June 22, 2022
Synmosa Biopharma : Announcement by Synmosa to dispose Real property. (Update sale profit and loss)
June 17, 2022
Synmosa Biopharma : Announcement the re-election of Directors (Including Independent Directors) of the Company
May 25, 2022
Synmosa Biopharma : Announcement of the election of the chairman of the board of directors of the company
May 25, 2022
Synmosa Biopharma : 2022 Shareholders' Meeting Major Resolutions Shareholders' Meeting
May 25, 2022
Synmosa Biopharma : 2022 Shareholders' Meeting approved the “lifting of non-competition restrictions on newly appointed directors and their representatives”case.
May 25, 2022
Synmosa Biopharma : Announcement of change in the Company's accounting officer and financial officer
March 29, 2022
Synmosa Biopharma : Board of Directors resolved to buy back common stocks
March 29, 2022
Synmosa Biopharma : The Board of Synmosa resolves to increase capital stock by earnings recapitalization
March 29, 2022
Synmosa Biopharma : Board of Directors approved dividend distribution
March 29, 2022
Synmosa Biopharma : The Company's 2021 consolidated financial statements have been reported to the Board
March 29, 2022
Synmosa Biopharma : Board of Directors resolved to convene the 2022 Annual Shareholders' Meeting
March 29, 2022